Cargando…

Comparison of Fetomaternal Outcomes in Patients With Gestational Diabetes Mellitus Treated With Insulin Versus Acarbose: Results of a Prospective, Open Label, Controlled Study

Objective To evaluate fetomaternal outcomes in patients with gestational diabetes mellitus (GDM) treated with insulin versus acarbose. Material and methods In this prospective, open label, controlled study, GDM patients treated with insulin or acarbose were observed till six weeks after delivery. Ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jayasingh, Suryakanta, Nanda, Saumya, Misra, Sujata, Baliarsinha, A, Das, Sidhartha, Patil, Anant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773288/ https://www.ncbi.nlm.nih.gov/pubmed/33403188 http://dx.doi.org/10.7759/cureus.12283

Ejemplares similares

Fetomaternal Outcome Among the Pregnant Women Subject to the Induction of Labor
por: Kazi, Sarah, et al.
Publicado: (2021)

Psychosocial deprivation in women with gestational diabetes mellitus is associated with poor fetomaternal prognoses: an observational study
por: Cosson, Emmanuel, et al.
Publicado: (2015)

Prevalence of Insulin Resistance in Type 1 Diabetes Mellitus and Its Correlation with Metabolic Parameters: The Double Trouble
por: Pathak, Vaibhav, et al.
Publicado: (2022)

Prevalence, Risk Factors, and Fetomaternal Outcomes of Gestational Diabetes Mellitus in Kuwait: A Cross-Sectional Study
por: Groof, Zainab, et al.
Publicado: (2019)

Effects of the addition of acarbose to insulin and non-insulin regimens in veterans with type 2 diabetes mellitus
por: Wettergreen, Sara A., et al.
Publicado: (2016)

Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus
por: Jin, Hongmei, et al.
Publicado: (2022)

Insulin Glargine and Acarbose in the treatment of elderly patients with diabetes
por: Li, Jing, et al.
Publicado: (2019)

Effects of yoga on cardiometabolic risks and fetomaternal outcomes are associated with serum nitric oxide in gestational hypertension: a randomized control trial
por: Karthiga, Kuzhanthaivelu, et al.
Publicado: (2022)

Fetomaternal outcomes in pregnant women with hepatitis E infection; still an important fetomaternal killer with an unresolved mystery of increased virulence in pregnancy
por: Kumar, Namrata, et al.
Publicado: (2017)

Retracted: Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Prognosticating Fetomaternal ICU Outcomes
por: Suri, Jyotsna, et al.
Publicado: (2021)

Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus
por: Wu, Honghua, et al.
Publicado: (2017)

Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Controlled with Basal Insulin Treatment: Randomized, Parallel, Open-Label, Active-Controlled Study
por: Lee, Mi Young, et al.
Publicado: (2014)

Trisomy 13 and Massive Fetomaternal Hemorrhage
por: Matsui, Ryoko, et al.
Publicado: (2015)

Long-term persistent fetomaternal hemorrhage
por: Umazume, Takeshi, et al.
Publicado: (2015)

Fetomaternal outcome of pregnancy with Mitral stenosis
por: Ahmed, Nazia, et al.
Publicado: (2015)

Fetomaternal outcome in patients with placenta previa
por: Wasim, Tayyiba, et al.
Publicado: (2020)

Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study
por: Ueno, Hiroaki, et al.
Publicado: (2015)

Acarbose is again on the stage
por: Altay, Mustafa
Publicado: (2022)

Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
por: Uzui, Hiroyasu, et al.
Publicado: (2011)

Comparison of adjunctive therapy with metformin and acarbose in patients with Type-1 diabetes mellitus
por: Ziaee, Amir, et al.
Publicado: (2017)

Fetomaternal alloimmunity as a cause of liver disease
por: Smyk, Daniel, et al.
Publicado: (2011)

Medawar’s Paradox and Immune Mechanisms of Fetomaternal Tolerance
por: Rendell, Victoria, et al.
Publicado: (2020)

Critically Ill Obstetric Patients and Fetomaternal Outcome
por: Bande, Balasaheb D
Publicado: (2020)

Fever During Pregnancy: Etiology and Fetomaternal Outcomes
por: Brar, Rinnie, et al.
Publicado: (2021)

Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose
por: Huang, Jie, et al.
Publicado: (2020)

Adverse fetomaternal outcome among pregnant overweight women
por: Awan, Shazia, et al.
Publicado: (2015)

Fetomaternal Acid–Base Balance and Electrolytes during Pregnancy
por: Ahmed, Armin
Publicado: (2021)

On the potential of acarbose to reduce cardiovascular disease
por: Standl, Eberhard, et al.
Publicado: (2014)

Predictors of acarbose therapeutic efficacy in newly diagnosed type 2 diabetes mellitus patients in China
por: Zhang, Rong, et al.
Publicado: (2022)

Gestational diabetes mellitus: Non-insulin management
por: Magon, Navneet, et al.
Publicado: (2011)

Prenatal Diagnosis and Fetomaternal Outcomes of Two Cases with Placental Chorioangioma
por: Artunc Ulkumen, Burcu, et al.
Publicado: (2013)

Acute and Chronic Fetal Anemia as a Result of Fetomaternal Hemorrhage
por: Singh, Paul, et al.
Publicado: (2014)

Evaluation of Automatic Blood Analyzer as Screening Method in Fetomaternal Hemorrhage
por: Cardoso, Marcella R., et al.
Publicado: (2019)

TIGIT-Fc as a Potential Therapeutic Agent for Fetomaternal Tolerance
por: Fu, Wenyan, et al.
Publicado: (2021)

Fetomaternal hemorrhage occurred in one fetus of dichorionic twin pregnancy
por: Sagawa, Kei, et al.
Publicado: (2021)

Ambulatory Blood Pressure Monitoring: Our Experience in Routine Clinical Practice
por: Dube, Sunil R, et al.
Publicado: (2021)

Clinical Characteristics and Management of Headache: A Real-Life Prospective, Observational Study From a Tertiary Care Center in Eastern India
por: Nayak, Soumyadarshan, et al.
Publicado: (2020)

The Effects of Gliclazide, Metformin, and Acarbose on Body Composition in Patients with Newly Diagnosed Type 2 Diabetes Mellitus()
por: Wang, Hua, et al.
Publicado: (2013)

Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: A Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fpaj4r55bepit106cbm3ug4h47